drugset / Trial / NCT00327379

Effect of Aprotinin on Transfusion Requirements in Patients Undergoing Elective Spinal Fusion Surgery

NCT00327379

Phase 3 Terminated 54 enrolled Bayer
RandomizedParallel-groupDouble-blindPrevention

Summary

The objective of this study is to evaluate the safety and efficacy of aprotinin as compared to placebo, in reducing the need for blood transfusion in adult subjects undergoing elective spinal fusion surgery involving 3 to 7 vertebral levels with instrumentation

Timeline

Start
2006-02-27
Primary completion
2007-03-01
Completion
2007-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Aprotinin Unknown 500000 unknown Other

Indications

No indication recorded.